BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Clover Completes BLA Submission for Seasonal Influenza Vaccine in Brazil

Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197), a global commercial-stage biotechnology company committed to unleashing the power of innovat...

November 07, 2023 | News

GC Biopharma Seeks South Korean MFDS Approval for World's First Recombinant Anthrax Vaccine.

'GC1109' contains protective antigen (PA) as its active pharmaceutical ingredients produced by recombinant DNA technology which delivers 2 types of protein...

November 06, 2023 | News

Thirty-One mRNA Leaders Launch First Global Organization Dedicated to Advancing mRNA Medicines

31 biotechnology, biopharma and life science companies and educational institutions at the forefront of mRNA and next-generation encoding RNA therapeutics ...

November 02, 2023 | News

YS Biopharma Completes Pivotal Phase 3 Enrollment for PIKA Rabies Vaccine Trial

Rabies has an almost 100% fatality rate upon emergence of clinical symptoms. Each year, it claims the lives of approximately 59,000 individuals in ...

November 01, 2023 | News

Rational Vaccines and Shenzhen Mellow Hope Partner on Herpes Vaccines in China

Rational Vaccines (RVx) and Shenzhen Mellow Hope Pharm Industrial Co., Ltd. (MH) announced they have reached an agreement to jointly develop, manufacture, ...

October 31, 2023 | News

FDA Approves PENBRAYA™: First Vaccine for 5 Common Meningococcal Serogroups in Teens

PENBRAYA™ provides the broadest serogroup coverage (meningococcal groups A, B, C, W and Y) of any meningococcal vaccine available in the U.S. ...

October 23, 2023 | News

Novavax's Nuvaxovid™ COVID-19 Vaccine Gains Full Approval in Singapore.

"The full approval of our prototype vaccine will enable us to file for approval of our updated protein-based non-mRNA COVID-19 vaccine in the coming w...

October 19, 2023 | News

Karikó and Weissman Win Nobel for COVID-19 mRNA Vaccine Work in 2023

These groundbreaking discoveries by both laureates were instrumental in the rapid development of mRNA vaccines during the early 2020 pandemic, revolutioniz...

October 04, 2023 | News

Novavax COVID-19 Vaccine Authorized and Recommended in U.S. for 2023-2024

This Emergency Use Authorization and CDC recommendation makes Novavax's vaccine the only protein-based non-mRNA COVID vaccine option in the U.S. No...

October 04, 2023 | News

WuXi Vaccines Launches Its First Vaccines CDMO Site in China

The opening will add drug substance and drug product capacity, with end-to-end services for diversified vaccines that will accelerate global clients' proje...

September 27, 2023 | News

Merck to Become First Provider to Offer Fully Integrated mRNA Services

New sites at Darmstadt and Hamburg complement Merck’s global integrated mRNA service network with pre-clinical to commercial capabilities Company&...

September 27, 2023 | News

Takara Bio Europe Launches Enzymes for mRNA Vaccine R&D

Takara Bio Europe (TBE) announced the launch of new High Quality (HQ) grade mRNA production enzymes "T7 RNA polymerase, HQ" and "Pyrophosphatas...

September 13, 2023 | News

Serbian Prime Minister Visits SK Bioscience for Vaccine Localization Partnership

Ana Brnabić, Prime Minister of Serbia visited the headquarters of SK bioscience. SK bioscience has signed a Memorandum of Understanding with th...

September 11, 2023 | News

ACM Biolabs Reports Positive Phase I Results for SARS-CoV-2 Booster Vaccine ACM-001

Provides clinical validation for ACM Biolab's Tunable Platform ("ATP™"), ACM Biolab's proprietary polymer-based delivery platform ACM-...

September 06, 2023 | News

Stay Connected